An investigational exosome-based liquid biopsy accurately detected 97% of stage 1-2 pancreatic cancers when combined with the biomarker CA 19-9, according to research presented at the American ...

UCSF scientists discover how cancer cells hijack the protein factory of the cell to churn out MYC protein, the driver of 70% ...

Liquid biopsy is a non-invasive method that can help detect and monitor cancer treatment It assesses neoplastic material from ...

The growth protein, MYC, was consistently found with RBM42, which spurs MYC production, in human pancreatic tumors. Above, microscopy for MYC (red ...

Apparently, the biopsy could not be taken because the ... but I would like for all GPs to be aware of the symptoms of pancreatic cancer and to know that jaundice is not the only sign.

These pancreatic lesions ... genetic predispositions, and cancer-specific biomarkers. Liquid biopsy is promising for screening, especially in asymptomatic individuals, as it opens the possibility ...

Comparison of mutational landscape in primary and metastatic pancreatic tumors. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This abstract does not include a ...

An experimental blood test for pancreatic cancer is being evaluated by a commercial laboratory, an important milestone toward making the test available for patients. An experimental blood test for ...

Like any other organ, the pancreas can develop tumours. However, not all tumours are cancerous, and pancreatic cancer has an aggressive nature and late diagnosis. Pancreatic cancer may be less ...